Atrys Health (XMAD:ATRY) EV-to-Revenue : 2.54 (As of Jun. 06, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Atrys Health EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Atrys Health's enterprise value is €512.2 Mil. Atrys Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €201.6 Mil. Therefore, Atrys Health's EV-to-Revenue for today is 2.54.

The historical rank and industry rank for Atrys Health's EV-to-Revenue or its related term are showing as below:

XMAD:ATRY' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.19 Med: 5.42 Max: 15.38
Current: 2.54

During the past 8 years, the highest EV-to-Revenue of Atrys Health was 15.38. The lowest was 2.19. And the median was 5.42.

XMAD:ATRY's EV-to-Revenue is ranked better than
75.41% of 1037 companies
in the Biotechnology industry
Industry Median: 7.83 vs XMAD:ATRY: 2.54

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-06), Atrys Health's stock price is €3.86. Atrys Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €2.62. Therefore, Atrys Health's PS Ratio for today is 1.47.

Atrys Health EV-to-Revenue Historical Data

The historical data trend for Atrys Health's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atrys Health EV-to-Revenue Chart

Atrys Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

10.46

11.57

6.08

4.38

2.47

Atrys Health Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial											6.08	-	4.38	-	2.47

Competitive Comparison of Atrys Health's EV-to-Revenue

For the Biotechnology subindustry, Atrys Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atrys Health's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atrys Health's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Atrys Health's EV-to-Revenue falls into.

Atrys Health EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Atrys Health's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	512.231	/	201.569
	=	2.54

Atrys Health's current Enterprise Value is €512.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Atrys Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €201.6 Mil.

Atrys Health (XMAD:ATRY) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Atrys Health's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	3.86	/	2.62
	=	1.47

Atrys Health's share price for today is €3.86.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €2.62.

Atrys Health EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Atrys Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Atrys Health (XMAD:ATRY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atrys Health SA (XMAD:ATRY) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

A2T:Germany

Address

c/ Provença, 392 planta baja, Barcelona, ESP, 08025

Website

http://www.atryshealth.com

Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.

Atrys Health (XMAD:ATRY) Headlines

No Headlines